Skip to main content
Premium Trial:

Request an Annual Quote

Wash. U. Gains Access to GeneChips, Sequencers

Premium

ST. LOUIS--Washington University recently closed deals with Affymetrix for GeneChip access and Amersham Pharmacia Biotech to purchase MegaBace sequencing machines. Affymetrix and the university signed an AcademicAccess agreement to grant the school's researchers use of the company's standard and custom GeneChip arrays, instrumentation, and software to monitor gene expression for research purposes. The arrangement, which includes standard terms, conditions, and volume discount pricing provisions, will allow all of the university's researchers broad access to GeneChip technology.

Under the Amersham contract, the university's school of medicine purchased nine MegaBace 1000 DNA sequencers for its activities contributing to the Human Genome Project. The university's medical school receives funding for the project from the US National Human Genome Research Institute at the US National Institutes of Health.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.